Related Experiment Video
Updated: Oct 10, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1
1Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado 80523-1870, USA.
Abstract:
Progression through the eukaryotic cell cycle is regulated by phosphorylation, which is catalyzed by cyclin-dependent kinases. Cyclin-dependent kinases are regulated through several mechanisms, including negative regulation by p21 (variously called CAP20, Cip1, Sdi1, and WAF1). It has been proposed that multiple p21 molecules are required to inhibit cyclin-dependent kinases, such that p21 acts as a sensitive buffer of cyclin-dependent kinase activity or as an assembly factor for the complexes formed by the cyclins and cyclin-dependent kinases. Using purified, full-length proteins of known concentration (determined by absorbance) and cyclin A-Cdk2 of known activity (calibrated with staurosporine), we find that a 1:1 molar ratio of p21 to cyclin A-Cdk2 is able to inhibit Cdk2 activity both in the binary cyclin A-Cdk2 complex and in the presence of proliferating cell nuclear antigen (PCNA). Our results indicate that the mechanism of p21 inhibition of cyclin A-Cdk2 does not involve multiple molecules of bound p21.
Insights
The cell cycle inhibitor p21 (also known as CAP20, Cip1, Sdi1, and WAF1) binds cyclin A-Cdk2 at a 1:1 ratio. This finding indicates that a single p21 molecule is sufficient to inhibit cyclin-dependent kinase activity.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Eukaryotic cell cycle progression relies on phosphorylation, catalyzed by cyclin-dependent kinases (CDKs).
- CDK activity is tightly regulated, with p21 (also known as CAP20, Cip1, Sdi1, and WAF1) acting as a negative regulator.
- Previous hypotheses suggested multiple p21 molecules are needed to inhibit CDKs, potentially buffering CDK activity or aiding complex assembly.
Purpose of the Study:
- To investigate the stoichiometry of p21 binding to cyclin A-Cdk2 complexes.
- To determine the mechanism by which p21 inhibits cyclin-dependent kinase activity.
Main Methods:
- Utilized purified, full-length proteins with precisely determined concentrations.
- Employed cyclin A-Cdk2 with activity calibrated using staurosporine.
- Assessed p21 inhibition of Cdk2 activity in both binary cyclin A-Cdk2 complexes and in the presence of proliferating cell nuclear antigen (PCNA).
Main Results:
- Demonstrated that a 1:1 molar ratio of p21 to cyclin A-Cdk2 effectively inhibits Cdk2 activity.
- Confirmed this inhibitory stoichiometry in both the absence and presence of PCNA.
- Provided evidence against models requiring multiple p21 molecules for inhibition.
Conclusions:
- The mechanism of p21 inhibition of cyclin A-Cdk2 does not require multiple p21 molecules.
- A single molecule of p21 is sufficient to inhibit cyclin A-Cdk2 activity in complexes.
- Challenges previous notions of p21 acting solely as a buffer or assembly factor requiring multimerization.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:54Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
Anaphase Promoting Complex
Negative Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...